Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2003-09-19
2008-09-23
Romeo, David (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S324000, C424S184100, C424S185100, C424S195110
Reexamination Certificate
active
07427655
ABSTRACT:
The present invention relates to synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid β which can be used alone or conjugated to an immunostimulatory molecule in an immunizing composition for inducing an immune response to amyloid β peptides and amyloid deposits.
REFERENCES:
patent: 6866849 (2005-03-01), Schenk
patent: 6962707 (2005-11-01), Schenk
patent: WO 95/31996 (1995-11-01), None
patent: WO 96/39834 (1996-12-01), None
patent: WO 99/27944 (1999-06-01), None
patent: WO 99/27949 (2000-06-01), None
patent: WO 00/72880 (2000-12-01), None
Ghanta et al., 1996, J. Biol. Chem. 271(47):29525-29528.
Maillere et al., 1995, Molecular Immunology 32(17/18): 1377-1385.
Yankner et al., Science, vol. 250, No. 4978. (Oct. 12, 1990), pp. 279-282.
Solomon et al., PNAS 1997 94: 4109-4112.
Pike et al., Journal of Neurosci. Apr. 1993;13(4):1676-87.
Frenkel, D. et al.: “Modulation of Alzheimer's beta-amyloid neurotoxicity by site-directed single-chain antibody.” Neuroimmunomodulation, vol. 6, No. 6, Nov. 1999, p. 444 XP008000881, 4thInternational Congress of the International Society for Neuroimmunomodulation; Lugano, Switzerland; Sep. 29-Oct. 2, 1999. ISSN: 1021-7401, abstract.
Solomon, B. et al.: “Disaggregation of Alzheimer Beta-Amyloid by Site-Directed Mab” Proceedings of the National Academy of Sciences of USA, National Academy of Science. Washington, US, vol. 94, Apr. 1997, pp. 4109-4112, XP002911322, ISSN: 0027-8424, the whole document.
Sigurdsson, Einar M. et al.: “Immunization with a nontoxic
onfibrillar amyloid-beta homologus peptide reduecs Alzheimer's disease-associated pathologhy in transgenic mice.” American Journal of Pathology, vol. 159, No. 2, Aug. 2001, pp. 439-447, XP008000840, ISSN: 0002-9440, the whole document.
Schenk, Dale et al.: “Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse.” Nature, 1999;400: pp. 173-177.
Aguado, T. et al.: “Meeting Report—Novel adjuvants currently in clinical testing Nov. 2-4, 1998, Foundation Mérieux, Annecy, France: A meeting sponsored by the World Health Organization.” Vaccine 17 (1999); pp. 2321-2328.
Pallitto, Monica M. et al.: “Recognition Sequence Design for Peptidyl Modulators of β-Amyloid Aggregation and Toxicity.” Biochemistry 1999, 38, pp. 3570-3578.
Futaki, S. et al.: “Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.” J. Biol. Chem. Feb. 23, 2001; 276 (8): 5836-40, abstract.
Martinez-Fong, D. et al.: “Nonenzymatic glycosylation of poly-L-lysine: a new tool for targeted gene delivery.” Hepatology Dec. 1994; 20(6): 1602-8.
Schwarzenberger, P. et al.: “Poly-L-lysine-based molecular conjugate vectors: a high efficiency gene transfer system for human progenitor and leukemia cells.” Am J Med Sci Feb. 2001; 321 (2): 129-36.
Wang, Y. et al.: “Endocytosis of horseradish peroxidase-poly-lysine conjugate by glomerular epithelial cells: an in vivo study.” J Pathol Oct. 1989; 159(2): 159-67.
Shen, W.C. et al.: “Disulfide spacer between methotrexate and poly(D-lysine). A probe for exploring the reductive process in endocytosis.” J Biol Chem Sep. 15, 1985; 260(20): 10905-8.
Peterson, P.K. et al.: “Polyamino acid enhancement of bacterial phagocytosis by human polymorphonuclear leukocytes and peritoneal macrophages.” Infect Immun Feb. 1984; 43(2): 561-6.
Deierkauf F.A., et al.: “Phygocytosis by rabbit polymorphonuclear leukocytes: the effect of albumin and polyamino acids on latex uptake.” J Cell Physiol Aug. 1977; 92(2): 169-75.
Di Nicola, M. et al.: “Large-scale feasibility of gene transduction into human CD34+ cell derived dendritic cells by adenoviral/polycation complex.” Br J Haematol Oct. 2000; 111(1):344-50.
Buschle M. et al.: “Transloading of tumor antigen-derived peptides into antigen-prsenting cells.” Proc Natl Acad Sci USA Apr. 1, 1997;94 (7): 3256-61.
Farmer, J.L. et al.: “Human immune response to cationized proteins. II. Characterization of interaction of cationized diphtheria toxoid with human mononuclear cells.” Cell Immunol Jan. 1993; 146(1): 198-209.
Frangione Blas
Sigurdsson Einar M.
Wisniewski Thomas
Darby & Darby P.C.
Gamett Daniel C
New York University
Romeo David
LandOfFree
Synthetic immunogenic but non amyloidogenic peptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic immunogenic but non amyloidogenic peptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic immunogenic but non amyloidogenic peptides... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3988580